1 2 1 2 1 2 1 2 1 2 1 300193 2 300193 R944 A 1003-3734 2015 04-0390 - 05 Progress on oral colon specific drug delivery system ZHOU Jie 1 2 ZHU Xiao-ning 1 2 ZHANG Yi 1 2 ZHOU Xin 1 2 CUI Yuan-lu 1 2 1 Reasearch Center of Traditional Chinese Medicine Tianjin University of Chinese Medicine Tianjin 300193 China 2 Tianjin State Key Laboratory of Modern Chinese Medicine Tianjin 300193 China Abstract Oral colon specific drug delivery system has gained more attention from investigators in recent years since it can improve local drug concentration and reduce dosage and side effects. The design principle preparation technology and in vitro / vivo evaluation methods of oral colon specific drug delivery system were summarized in this paper to provide theoretical basis and reference for the development of oral colon specific drug delivery system. Key words colon specific drug delivery system preparation technology evlaution methods 20 90 1 1 6 2 2 3-5 7 ph 2012ZX09304007 18722122605 E-mail rhea1373879236@ 163. com 022 59596170 E-mail cuiyl @ tju. edu. cn 390 ph
1. 1 ph 16 HPMC ph EC HPMC γ- ph ph 5-5-ASA ph 1. 3 Gao 8 CPVA-g-PSSS MTZ ph ph = 1 Jeong 17 ph = 7. 4 EC HPMC 9 HPMCAS 10 ph -Eudragit100 PEG EC EC ph ph 18 Kovačič 11 ph 1. 2 McLeod 20 - HPMC Time Clock 12 5-ASA 21 Wilding 13-14 1. 4 Stella 19 1951 5-ASA Amal 22 Wu 15 HPMC 5- L- α- β- HPMC Zhiz 23 β- MTZ MTZ 391
9. 5% 43. 6% Maestrelli 30 24 h 100% Riberio 31 / 24 β- Jose 32 /ph β- 25 Eudragit S-100 3 β- ph = 6. 8 33 34 35 36 Miloslava 3 26 3 27 37 / Jerry 38 Dhawan 28 ph Dai 39 2 1. 5 2. 1 ph Mirela 29 ph Eudragit FS 30 D ph / ph 392
ph Kotla 40 Sharna 41 89% 2. 2 γ- 42 43 - X- 45 46 Ursekar 47 CPM 9 h 24 h 1. M. 90% Maurer 48 1998 281-282. 13 C 15 2 PINTO JF. Site-specific drug delivery systems within the gastrointestinal tract from the mouth to the colon J. Int J Pharm N 2 2010 395 1-2 44-52. 3 RABI KOV M BAUTZOV T GAJDZIOK J et al. Coated FITC - chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease In vitro characteristics and in vivo eval- uation J. Int J Pharm 2012 422 1-2 151-159. 4. J. 2013 38 6 817-820. 5. J. 2014 39 9 1603-1606. 6 KUMAR P MISHRA B. Colon targeted drug delivery systems-an overview J. Curr Drug Deliv 2008 5 3 186-198. 7 QURESHI AM MOMIN M RATHOD S et al. Colon targeted drug delivery system a review on current approaches J. Indian 3 J Pharm 2013 1 4 130-147. 8 GAO B FANG L MEN J et al. Preparation of grafted microspheres CPVA-g-PSSS and studies on their drug-carrying and co- lon-specific drug delivery properties J. Mat Sci Eng C 2013 33 3 1300-1306. 9. mtor J. 2012 34 393
23 2399-2405. lon-specific drug delivery system J. Pharm Dev Tech 2012 17 10. 4 429-436. J. 2014 39 1 71-74. 11 KOVACIC B VRECER F PLANINSEK O. Design of a drug delivery system with biomodal ph dependent release of a poorly soluble drug J. Die Pharmaize-An Int J Pharm Sci 2011 66 6 465-466. 12 POZZI F FURLANI P GAZZANIGA A et al. The time clock system a new oral dosage form for fast and complete release of drug after a predetermined lag time J. J Control Release 1994 31 1 99-108. 13 WILDING IR DAVIS S POZZI F et al. Enteric coated timed release systems for colonic targeting J. Int J Pharm 1994 111 1 99-102. 14 STEED KP HOOPER G MONTI N et al. The use of pharmaeoseintigraphy to focus the development strategy for a novel 5-ASA colon targeting system TIME CLOCK system J. J Control Release 1997 49 2 115-122. 15 WU B SHUN N WEI X et al. Characterization of 5-fluorouracil release from hydroxy propylmethyl cellulose compression-coated tablets J. Pharm Dev Technol 2007 12 2 203-210. 30 MAESTRELLI F CIRRI M CORTI G et al. Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery J. Eur J Pharm Biopharm 2008 69 2 508-518. 31 RIBEIRO L ANA CS MARGARITA D et al. Pectin-coated chitosan-ldh bionanocomposite beads as potential systems for colon-targeted drug delivery J. Int J Pharm 2014 463 1 1-9. 32 JOSE S PREMA MT CHACKO AJ et al. Colon specific chitosan microspheres for chronotherapy of chronic stable angina J. Colloids Surf B Biointerfaces 2011 2 83 277-283. 33. D.. 2013. 34. J. 2011 17 17 33-36. 35. -β- J. 2013 36 21 2956-2959. 36. D.. 2011. 37 DI PG ZEMA L WILSON DI et al. Optimisation and scale-up 16. J. of a highly-loaded 5-ASA multi-particulate dosage form using a 2003 34 34 172-175. 17 JEONG YI OHNO T HU Z et al. Evaluation of an intestinal pressure controlled colon delivery capsules prepared by a dipping method J. J Control Release 2001 71 2 175-182. 18 LAUTENSCHLAGER C SCHMIDT C FISCHER D et al. Drug delivery strategies in the therapy of inflammatory bowel disease J. Adv Drug Deliv Rev 2014 71 58-76. 19 STELLA VJ HIMMELSTEIN KJ. Prodrug and site specific drug delivery J. J Med Chem 1980 23 12 1275-1282. 20 MCLEOD AD FRIEND DR THOMA NT. Glucocorticoid-dextran conjugates as potential prodrugs for colon specific deliveryhydrolysis in rat gastrointestinal tract contents J. J Pharm Sci 1994 83 9 1284-1288. 21 TAKADA K. Controlled-release preparations U. S. Patent 5 637 319 P. 1997-6 - 10. 22 E1-KAMEL AH ABDEL-AZIZ AA FATANI AJ et al. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases Synthesis in vitro and in vivo assessment J. Int J Pharm 2008 358 1-2 248-255. 23 ZHIZ W BENP L PEIP M et al. Preparation and in vitro evaluation of macrocyclic metronidazole J. Incl Phenom Macrocycl Chem 2014 78 501-504. 24 SHAH N SHAH T AMIN A. Polysaccharides a targeting strategy for colonic drug delivery J. Expert Opin Drug Deliv 2011 8 6 779-796. factorial approach J. Eur J Pharm Sci 2012 45 1-2 158-168. 38 JERRY Y. Stimuli-responsive drug delivery system J. Adv Drug Deliv Rev 2012 64 11 965-966. 39 DAI J WU S JIANG W et al. Facile synthesis of pectin coated Fe3O4 nanospheres by the sonochemical method J. J Magn Magn Mater 2013 331 62-66. 40 KOTLA NG GULATI M SINGH SK et al. Facts fallacies and future of dissolution testing of polysaccharide based colon-specific drug delivery J. J Controll Release 2014 178 55-62. 41 SHARNA R RAWAL R K MALHOTRA M et al. Design synthesis and ex-vivo release studies of colon-specific polyphosphazene-anticancer drug conjugates J. Bioorg Med Chem 2014 22 3 1104-1114. 42 SUBHABROTA M SOUVIK R SUBHADEEP C. Preparation and gamma scintigraphic evaluation of colon specific pellets of ketoprofen prepared by powder layering technology J. Daru 2011 19 1 47-56. 43. J. 2012 21 3 315-331. 44 RISHABH S DEEPESH K KAMLA P. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet J. Int J Pharm 2012 427 2 153-162. 45. J. 25. 2014 23 16 1868-1874. J. 2006 41 8 604-607. 26 SABAA MW. Chitosan-g-Copolymers Synthesis Properties and 46. J. 2006 15 24 2140-2143. Application M / /Polysaccharide Based Graft Copolymers. 47 URSEKAR BM SONI PS DATE AA et al. Characterization of Springer Berlin Heidelberg 2013 111-147. soy polysaccharide and its in vitro and in invo evaluation for ap- 27. plication in colon drug delivery J. AAPS Pharm Sci Tech D. 2010. 28 DHAWAN S SINGLA AK SINHA VR. Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods J. AAPS Pharm Sci Tech 2004 5 4 122-128. 29 MIRELA FR ADRIANO VR ADONILSONDOS RF et al. A 2012 13 3 934-943. 48 MAURER MJ SCHELLEKENS RC WUTZKE KD et al. Isotope-labelled urea to test colon drug delivery devices in vivo principles calculations and interpretations J. Isotopes Environ Health Stud 2013 49 4 473-491. ph /enzyme-responsive polymer film consisting of Eudragit FS 30 D and arabinoxylane as a potential material formulation for co- / 2014-11 - 20 394